Visual assessment of [18F]flutemetamol PET images can detect early amyloid pathology and grade its extent
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1619-7089
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Visual assessment of [18F]flutemetamol PET images can detect early amyloid pathology and grade its extent ; day:22 ; month:2 ; year:2021 ; pages:1-14
European journal of nuclear medicine and molecular imaging ; (22.2.2021), 1-14
- Urheber
-
Collij, Lyduine E.
Salvadó, Gemma
Shekari, Mahnaz
Lopes Alves, Isadora
Reimand, Juhan
Wink, Alle Meije
Zwan, Marissa
Niñerola-Baizán, Aida
Perissinotti, Andrés
Scheltens, Philip
Ikonomovic, Milos D.
Smith, Adrian P. L.
Farrar, Gill
Molinuevo, José Luis
Barkhof, Frederik
Buckley, Christopher J.
Berckel, Bart N. M. van
Gispert, Juan D.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s00259-020-05174-2
- URN
-
urn:nbn:de:101:1-2021050719053985497249
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:00 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Collij, Lyduine E.
- Salvadó, Gemma
- Shekari, Mahnaz
- Lopes Alves, Isadora
- Reimand, Juhan
- Wink, Alle Meije
- Zwan, Marissa
- Niñerola-Baizán, Aida
- Perissinotti, Andrés
- Scheltens, Philip
- Ikonomovic, Milos D.
- Smith, Adrian P. L.
- Farrar, Gill
- Molinuevo, José Luis
- Barkhof, Frederik
- Buckley, Christopher J.
- Berckel, Bart N. M. van
- Gispert, Juan D.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Heterogeneity of Alzheimer’s disease: consequence for drug trials?
Diagnostic Impact of CSF Biomarkers in a Local Hospital Memory Clinic Revisited
A decade of Alzheimer’s Research & Therapy: reflections on the past, present, and future
Prevention of depression and sleep disturbances in elderly with memory-problems by activation of the biological clock with light - a randomized clinical trial
The “rights” of precision drug development for Alzheimer’s disease
Testing Episodic Memory in Elderly Subjects: Not as Simple as It Looks
Altered distribution of the EphA4 kinase in hippocampal brain tissue of patients with Alzheimer’s disease correlates with pathology
Eyes-closed task-free electroencephalography in clinical trials for Alzheimer’s disease: an emerging method based upon brain dynamics
Clinical Features of Patients with Alzheimer’s Disease and a History of Traumatic Brain Injury
Diagnostic impact of [18F]flutemetamol PET in early-onset dementia
Unbiased estimates of cerebrospinal fluid β-amyloid 1–42 cutoffs in a large memory clinic population
Amyloid-β peptides in cerebrospinal fluid of patients with dementia with Lewy bodies
Heterogeneity of Alzheimer’s disease: consequence for drug trials?
Diagnostic Impact of CSF Biomarkers in a Local Hospital Memory Clinic Revisited
A decade of Alzheimer’s Research & Therapy: reflections on the past, present, and future
Prevention of depression and sleep disturbances in elderly with memory-problems by activation of the biological clock with light - a randomized clinical trial
The “rights” of precision drug development for Alzheimer’s disease
Testing Episodic Memory in Elderly Subjects: Not as Simple as It Looks
Altered distribution of the EphA4 kinase in hippocampal brain tissue of patients with Alzheimer’s disease correlates with pathology
Eyes-closed task-free electroencephalography in clinical trials for Alzheimer’s disease: an emerging method based upon brain dynamics
Clinical Features of Patients with Alzheimer’s Disease and a History of Traumatic Brain Injury
Diagnostic impact of [18F]flutemetamol PET in early-onset dementia
Unbiased estimates of cerebrospinal fluid β-amyloid 1–42 cutoffs in a large memory clinic population
Amyloid-β peptides in cerebrospinal fluid of patients with dementia with Lewy bodies
Heterogeneity of Alzheimer’s disease: consequence for drug trials?
Diagnostic Impact of CSF Biomarkers in a Local Hospital Memory Clinic Revisited
A decade of Alzheimer’s Research & Therapy: reflections on the past, present, and future
Prevention of depression and sleep disturbances in elderly with memory-problems by activation of the biological clock with light - a randomized clinical trial
The “rights” of precision drug development for Alzheimer’s disease
Testing Episodic Memory in Elderly Subjects: Not as Simple as It Looks
Altered distribution of the EphA4 kinase in hippocampal brain tissue of patients with Alzheimer’s disease correlates with pathology
Eyes-closed task-free electroencephalography in clinical trials for Alzheimer’s disease: an emerging method based upon brain dynamics
Clinical Features of Patients with Alzheimer’s Disease and a History of Traumatic Brain Injury
Diagnostic impact of [18F]flutemetamol PET in early-onset dementia
Unbiased estimates of cerebrospinal fluid β-amyloid 1–42 cutoffs in a large memory clinic population